MST Medical Surgery Technologies Ltd.

www.mst-sys.com

Now TransEnterix Israel

High-Tech Company

Acquired by TransEnterix

Graduated from: NGT

TECH VERTICALS

Artificial Intelligence, Computer Vision, Healthtech, Machine Vision, Medical Devices, MedTech, Robotics

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2005
Number of Employees	25
Reg. Number:	abCDe

DESCRIPTION

MST Medical Surgery Technologies is commercializing the AutoLap system, a clinically validated image based robotic system for the multi-billion dollar laparoscopic minimally invasive surgery market. The AutoLap brings advanced video analytics into the OR and provides stable imaging for HD devices. MST's cost efficient robotic manipulator enables the surgeons full control of the laparoscope's movement and positioning. It provides extreme image stability, natural surgical workflow and reduces the need for coordination and communication between surgeons and assistants. The company's future versions include innovative and unique, minimally invasive robotic manipulator systems, based on MST's propriety "press and follow" approach. These robotic manipulators are designed to support next generation advanced laparoscopes, such as HD laparoscopes, 4KHD and 3D imaging.

TECHNOLOGY

MST uses advanced video analytics and a custom designed robotic manipulator to allow surgeons to independently move and hold laparoscopes in a stable, synchronized and precise manner. The AutoLap (TM) laparoscope positioning device tracks and follows surgical tools at a press of a button . The surgeon control the robotic system via a disposable joystick ring that clips onto the surgeon’s finger or instruments. The AutoLap device has been clinically validated and is currently commercialized.

	TARGET MARKETS
	Surgeons, Hospitals, Ambulatory Surgical Centers (ASCs)

	BUSINESS MODEL
	B2B2C

COMPETITORS

EndoControl , Prosurgics Ltd.

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Patent Attorneys
abC Defghij	Law Firm
abC Defghij	Accounting Firm

CONTACT INFO

Expand / Collapse All

Main Address: Yoqneam, Israel

Address	Kochav Yokneam Building, FL 5, Yoqneam Ilit
POB	685
City	Yoqneam
Country	Israel
Zip	20692

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Hillsboro, United States

Address	235 Apollo Beach Blvd. #264 Apollo Beach
City	Hillsboro
State/Province	FL
Country	United States
Zip	33572-225

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Essen, Germany

Address	Am Deimelsberg 37
City	Essen
Country	Germany
Zip	45276

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Ziv Dov Tamir	Co-Founder
Mr. Moti Sholev	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Founder & Managing Director, SCP Vitalife
abC Defghij	Board Member	Investor Relations Manager, SCP Vitalife
abC Defghij	Board Member	Managing Director of Jacobs Investment Company LLC (JIC).
abC Defghij	Board Member	Co-founder, Chairman and General Manager, Haisco Pharmaceutical Group
abC Defghij	Scientific Advisor	Director of the Center for Innovative Surgery, Hadassah-Hebrew University Medical Center
abC Defghij	Scientific Advisor	Director, Center for Innovative Surgery, Hadassah-Hebrew University Medical Center
abC Defghij	Scientific Advisor	Head of Minimally Invasive Gynecology, Founder and Head of the Multidisciplinary Center for the Treatment of Endometriosis, Carmel Medical Center Department of Obstetrics & Gynecology

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Sep. 23, 2018

Initial Revenues

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Fifth Round - Extended

Jan. 09, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe

Fifth Round

Aug. 10, 2017

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Angel Syndicate	abCDe
abC Defghij	High-Tech Company	abCDe

Fourth Round

Feb. 24, 2015

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Angel Syndicate	abCDe
abC Defghij	High-Tech Company	abCDe	Led the round

Third Round

Oct. 23, 2013

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Angel Syndicate	abCDe

Second Round

Mar. 01, 2011

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

First Round

Jun. 01, 2008

R&D

abCDe

Seed

May. 29, 2005

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

May. 29, 2005

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe